The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The FGFR-inhibitor derazantinib (DZB) is active in PDX-models of GI-cancer with specific aberrations in FGFR.
 
Paul McSheehy
Employment - Basilea; Basilea; Basilea; Basilea
Stock and Other Ownership Interests - Basilea; Basilea; Basilea; Basilea
 
Felix Bachmann
Employment - Basilea; Basilea; Basilea; Basilea
Stock and Other Ownership Interests - Basilea; Basilea; Basilea; Basilea
 
Nicole Forster-Gross
Employment - Basilea; Basilea; Basilea; Basilea
 
Mahmoud El Shemerly
Employment - Basilea; Basilea; Basilea; Basilea
 
Mila Roceri
Employment - Basilea; Basilea; Basilea; Basilea
 
Laurenz Kellenberger
Employment - Basilea; Basilea; Basilea; Basilea
Leadership - Basilea; Basilea; Basilea; Basilea
Stock and Other Ownership Interests - Basilea; Basilea; Basilea; Basilea; Novartis; Novartis; Novartis; Novartis; Roche; Roche; Roche; Roche
 
Heidi A Lane
Employment - Basilea; Basilea; Basilea; Basilea
Stock and Other Ownership Interests - Basilea; Basilea; Basilea; Basilea; Clinuvel; Clinuvel; Clinuvel; Clinuvel; Eiger BioPharmaceuticals; Eiger BioPharmaceuticals; Eiger BioPharmaceuticals; Eiger BioPharmaceuticals; Roche; Roche; Roche; Roche